SCHEMBL14494158

SCHEMBL14494158

CC(C)OCc1ccc2[nH]c3c4c(c5c(c3c2c1)CNC5=O)-c1ccccc1C4

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 15/20 1.00
▸ MAP3K9 P80192 6/20 0.64
▸ MAP3K11 Q16584 6/20 0.64
▸ MAP3K10 Q02779 3/20 0.64
▸ NTRK1 P04629 2/20 0.64
▸ PRKD3 O94806 1/20 0.64
▸ PRKCG P05129 1/20 0.64
▸ PRKCB P05771 1/20 0.64
▸ PRKCA P17252 1/20 0.64
▸ PRKCH P24723 1/20 0.64
▸ PRKCI P41743 1/20 0.64
▸ PRKCE Q02156 1/20 0.64
▸ PRKCQ Q04759 1/20 0.64
▸ PRKCZ Q05513 1/20 0.64
▸ PRKCD Q05655 1/20 0.64
▸ PRKD1 Q15139 1/20 0.64
▸ PDGFRB P09619 1/20 0.61
▸ KIT P10721 1/20 0.61
▸ FGFR1 P11362 1/20 0.61
▸ FLT1 P17948 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14494156 0.88 KDR (0.79) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL14494154 0.85 KDR (0.74) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL14494166 0.82 KDR (0.69) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL14494163 0.81 MAP3K9 (0.69) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL14494184 0.81 MAP3K9 (0.72) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL14510328 0.80 KDR (0.67) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL3268039 0.80 MAP3K9 (0.76) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL3072275 0.79 MAP3K11 (1.00) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL3268623 0.78 MAP3K9 (0.73) KDRMAP3K9MAP3K11MAP3K10NTRK1
SCHEMBL25779628 0.78 KDR (0.84) KDRPDGFRBKITFGFR1FLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230026-B2 Administering fused pyrrolocarbazole compound for therapy of prostate disorders CEPHALON, INC. (US) 2007-06-12 — — US disclosed
US-7230026-B2 Administering fused pyrrolocarbazole compound for therapy of prostate disorders CEPHALON, INC. (US) 2007-06-12 — — US disclosed
Send feedback